ReviewFrontiers in cell and developmental biology2026
Bridging innate immunity and iron-dependent death: the interplay between cyclic GMP-AMP synthase-stimulator of interferon genes nexus and ferroptosis in cancer and inflammation.
Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway and ferroptosis have emerged as fundamental biological mechanisms that converge in regulating cellular homeostasis and disease pathogenesis. As a central component of innate immunity, the cGAS-STING axis detects cytosolic double-stranded DNA through cGAS-mediated synthesis of 2'3'-cyclic GMP-AMP, subsequently triggering STING-dependent activation of the TBK1-IRF3 and nuclear factor-κB signaling cascades. Ferroptosis, an iron-catalyzed form of regulated cell death, is characterized by the accumulation of phospholipid hydroperoxide due to compromised antioxidant activity and dysregulated iron metabolism. Accumulating evidence has revealed the intricate crosstalk between these pathways. This review systematically explores the structural and biochemical bases of both pathways, identifies key bridging molecules that mediate their interactions, and discusses therapeutic strategies targeting this crosstalk, particularly in cancer treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.